Main Article Content
Abstract
The diagnosis of Lucio's leprosy is difficult because cutaneous manifestations are often atypical. Patients often come in severe conditions accompanied by Lucio phenomenon. A 33 years old man had a major complaint of purplish blue spots and ulcers accompanied by blisters for the past four days. The patient's eyebrows and eyelashes have been lost for the past year, but there were no prior histories of painless skin lesions and nerve impairment. Dermatological examination showed multiple stellate purpuric patches scattered almost throughout the body. There were also numerous bullas and erosions covered by dark necrotic areas, mainly on extremities. These involved about 40% of his Body Surface Area (BSA). The slit skin smears revealed BI 6+ and MI 1%. Hematoxylin and Eosin histopathology examination revealed a granulomatous inflammatory reaction accompanied by vasculitis. While Ziehl Neelsen's staining revealed abundant acid-fast bacilli scattered in the dermis area, some infiltrated vascular endothelial walls supported a Lucio phenomenon. The patient also had severe anemia, neutrophilia, hyperkalemia, and hypoalbuminemia. The extent of skin lesions and septic conditions complicate the management and lead to high levels of morbidity and mortality. Lucio's phenomenon is a severe leprosy reaction that is difficult to recognize with necrotizing erythematous cutaneous lesions as characteristic clinical manifestations, especially on the extremities. Extensive involvement of the lesion and sepsis were the main obstacles that were encountered during this case management. The administration of multidrug therapy for multibacillary leprosy (MDT-MB) WHO regimens are the primary therapy that can be combined with systemic corticosteroids.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
DOI:10.1093/qjmed/hcz146
2. Sharma P, Kumar A, Tuknayat A, et al. Lucio phenomenon: A rare presentation of Hansen’s disease. J Clin Aesthet Dermatol. 2019;12(12):35–8.
3. Ahuja M, Lavania M, Singh I, et al. Detection of Mycobacterium lepromatosis in patients with leprosy in India. Infect Drug Resist. 2018;736–45. 10.2147/IDR.S166035
4. Ya SNC, Muhamad R, Zakaria R, et al. Lucio Phenomenon: Sequelae of Neglected Leprosy. Korean J Fam Med. 2021;42(3):245–9. 10.4082/kjfm.19.0068
5. Rocha RH, Emerich PS, Diniz LM, et al. Lucio’s phenomenon: Exuberant case report and review of Brazilian cases. An Bras Dermatol. 2016;91(5):60–3.
10.1590/abd1806-4841.20164370
6. Chauhan A, Palit A, Singal A, et al. IAL Textbook of Leprosy: Second Edition. 2017. p542–543.
DOI: https://doi:10.5005/jp/books/12958
7. William James, Elston D, Treat J, et al. Andrews’ Diseases of the Skin Clinical Dermatology. 13th ed. 2019. 862 p.
8. Ramal C, Casapia M, Marin J, et al. Diffuse multibacillary leprosy of Lucio and Latapí with Lucio’s Phenomenon, Peru. Emerg Infect Dis. 2017;23(11):1929–30.
DOI:10.3201/eid2311.171228
9. Quiz P. Anthony Amoroso, Ajit P . Limaye, Section Editor A Young Woman With Ulcerated Skin Lesions on Her Lower Extremities. 2020;71:2–5.
DOI: 10.1093/cid/ciz1012
10. Faye O, Dicko A, Traore B, et al. Diffuse Necrotic Ulcerations Revealing Lepromatous Leprosy with Lucio’s Phenomenon. Der-matology Case Reports. 2017;02(02):2–3.
11. Rosli N. Lucio’s phenomenon in untreated advanced leprosy. Hum Pathol Case Reports. 2020;21(August):200413. 10.1016/j.ehpc.2020.200413
12. Miyashiro D, Cardona C, Valente NYS, Avancini J, Benard G, Trindade MAB. Ulcers in leprosy patients, an unrecognized clinical manifestation: A report of 8 cases. BMC Infect Dis. 2019;19(1):1–5.
13. Kaur M, Patra S, Asati DP, et al. Lucio phenomenon in a patient of lepromatous leprosy from India. Indian J Dermatol Vene-reol Leprol. 2021;87(1):67–70.
doi:10.25259/IJDVL_114_20